Sequence variants of ACE, AGT, AT1R, and PAI-1 as genetic risk factors for vascular dementia

Neurosci Lett. 2006 Jul 3;401(3):276-9. doi: 10.1016/j.neulet.2006.03.035. Epub 2006 Apr 17.

Abstract

Sequence variants of angiotensin converting enzyme (ACE) insertion/deletion (I/D), angiotensinogen (AGT) T235M, angiotensin II type 1 receptor (AT1R) A1166C, and plasminogen activator inhibitor-1 (PAI-1) 4G/5G were analyzed to see their genetic associations with vascular dementia as its candidate genetic risk factors involving renin-angiotensin and fibrin systems. While the ACE I/D, AT1R A1166C, and PAI-1 4G/5G did not contribute to the genetic susceptibility to vascular dementia (P>0.05), a significant association with vascular dementia was shown in the T235M polymorphism of AGT. The frequency of the M allele in patients was higher than in controls with the odds ratio (OR) estimate of 1.51 (P<0.05). In a dominant model, the TM+MM genotypes increased the risk of vascular dementia compared to the TT genotype (OR=2.01; P<0.001). The current results suggested that AGT T235M polymorphism might be a risk factor of vascular dementia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiotensinogen / genetics*
  • DNA Mutational Analysis / methods
  • Dementia, Vascular / genetics*
  • Female
  • Genetic Variation*
  • Humans
  • Male
  • Methionine / genetics
  • Middle Aged
  • Odds Ratio
  • Peptidyl-Dipeptidase A / genetics*
  • Plasminogen Activator Inhibitor 1 / genetics*
  • Receptor, Angiotensin, Type 1 / genetics*
  • Risk Factors
  • Tyrosine / genetics

Substances

  • Plasminogen Activator Inhibitor 1
  • Receptor, Angiotensin, Type 1
  • Angiotensinogen
  • Tyrosine
  • Methionine
  • Peptidyl-Dipeptidase A